RTORentokil Initial Plc.
Slide 1 of 3
Company Overview
Name
Rentokil Initial Plc.
52W High
$31.81
52W Low
$19.39
Market Cap
$16B
Dividend Yield
0%
Price/earnings
0.1524
P/E
0.1524
Dividends
Dividends Predicted
Mar 14, 2026
$0.19 per share
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$6.8B
Operating Revenue
$6.8B
Total Gross Profit
$757.5M
Total Operating Income
$687.4M
Net Income
$384.4M
EV to EBITDA
$18.80
EV to Revenue
$2.90
Price to Book value
$3.02
Price to Earnings
$41.52
Additional Data
Impairment Charge
$70.1M
Total Operating Expenses
$-70.1M
Interest Expense
$-246.7M
Interest & Investment Income
$57.6M
Other Income / (Expense), net
$8.8M
Total Other Income / (Expense), net
$-180.3M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Rentokil Initial Plc.
52W High
$31.81
52W Low
$19.39
Market Cap
$16B
Dividend Yield
0%
Price/earnings
0.1524
P/E
0.1524
Dividends
Dividends Predicted
Mar 14, 2026
$0.19 per share
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$6.8B
Operating Revenue
$6.8B
Total Gross Profit
$757.5M
Total Operating Income
$687.4M
Net Income
$384.4M
EV to EBITDA
$18.80
EV to Revenue
$2.90
Price to Book value
$3.02
Price to Earnings
$41.52
Slide 4 of 5
Additional Data
Impairment Charge
$70.1M
Total Operating Expenses
$-70.1M
Interest Expense
$-246.7M
Interest & Investment Income
$57.6M
Other Income / (Expense), net
$8.8M
Total Other Income / (Expense), net
$-180.3M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
N/A
Location
N/A, United Kingdom
Exchange
NYSE
Summary
N/A
Company Info
CEO
N/A
Location
N/A, United Kingdom
Exchange
NYSE
Summary
N/A
Company FAQ
@autobot 4 weeks ago | 2025 - q4
What does this company do? What do they sell? Who are their customers?
Rentokil Initial plc is the world's largest pest control company, headquartered in the United Kingdom and publicly traded on the NYSE as an American Depositary Receipt (ADR). The company specializes in pest management services for commercial and residential customers. Rentokil's core clientele includes businesses such as hotels, restaurants, food processing plants, healthcare facilities, and property management firms, as well as individual homeowners. Over the years, Rentokil has established a recurring revenue business model, prioritizing high customer retention and low capital requirements. With a global presence, particularly strengthened by its $6B acquisition of Terminix in 2022, Rentokil now holds a dominant position in the U.S. pest control market.
What are the company’s main products or services?
Pest control services for commercial and residential customers, including the eradication and prevention of common pests such as rodents, insects, and termites.,Specialist hygiene and sanitation services for workplaces and public facilities.,Termite protection and elimination services, enhanced through the recent Terminix acquisition.,Environmental and vector control solutions tailored for sensitive industries, such as food safety.,Disinfection and sanitization solutions for health and safety compliance in business environments.
Who are the company’s main competitors?
Rollins Inc. (Orkin),Ecolab,Anticimex,ServiceMaster Global Holdings (formerly, now the Terminix brand is part of Rentokil),Massey Services
What drives the company’s stock price?
The primary drivers of Rentokil's stock price include its earnings results, especially trends in recurring revenue and margin growth, and ongoing integration of large acquisitions like Terminix. Analyst upgrades—such as Zacks raising its rating to #2 (Buy)—and hedge fund activity, such as Trian Partners' and Voss Capital's significant stakes, are also influencing price momentum and investor sentiment. The broader success of its U.S. strategy, performance improvements post-acquisitions, and general macroeconomic events such as inflation easing play notable roles. Integration costs, operational synergies, and updates from leadership regarding shareholder value strategies further move the stock. Additionally, Rentokil's defensive business model offers resilience in uncertain market conditions, attracting investor attention during volatility.
What were the major events that happened this quarter?
This most recent quarter saw Rentokil continue integrating the $6B Terminix acquisition, with the process still facing some challenges that impacted operational and stock performance. Hedge fund Trian Partners, led by Nelson Peltz, disclosed a top-10 shareholder stake and began engaging the company on ways to enhance shareholder value, resulting in a nearly 14% rebound for the ADRs. Several investment managers—including Voss Capital and Vulcan Value Partners—identified Rentokil as a strong long-term investment, citing its scale and recurring revenue. The company was also added to a number of value-focused institutional portfolios, signaling increased confidence from sophisticated investors. However, Rentokil is not yet among the most heavily-held stocks by hedge funds, according to recent tallies.
What do you think will happen next quarter?
For the upcoming quarter, analysts expect continued focus on the integration of Terminix, with incremental operational improvements likely as synergies are realized and costs are optimized. The investment community will watch for updates on Terminix-related cost savings and cross-selling opportunities in the large U.S. market. Rentokil may announce additional strategic moves to further consolidate its dominance in pest control, possibly through smaller acquisitions or new partnerships. Given recent positive earnings estimate revisions and fund inflows, modest revenue and net income growth are anticipated. Investor scrutiny will remain high regarding post-merger performance and updates from activist shareholders or management on unlocking further shareholder value.
What are the company’s strengths?
Rentokil’s primary strengths include its scale and leadership as the largest pest control provider globally. Its business model is characterized by high levels of recurring revenue, robust customer retention, and low ongoing capital expenditures. The company’s competitive edge is further enhanced by its successful expansion into the U.S. market via the blockbuster Terminix acquisition, which now positions it as the market leader in that geography. Rentokil’s resilience to economic downturns, due to the necessity of pest control services, provides an additional defensive aspect to its portfolio. Its ability to integrate and extract value from acquisitions has historically enabled above-industry growth and margin expansion.
What are the company’s weaknesses?
The biggest vulnerabilities Rentokil faces currently center on the ongoing integration of the large-scale Terminix acquisition, which has led to operational disruptions and short-term challenges. These integration issues have weighed on financial performance and contributed to recent stock price volatility. The company’s relatively high valuation multiples, such as a P/E of over 38, suggest that expectations are high and may be difficult to meet if growth slows or synergies take longer than anticipated to materialize. Limited presence in fast-growth emerging markets compared to its global peers could be a strategic weakness. Rentokil’s dividend yield is currently at zero, potentially turning away income-focused investors.
What opportunities could the company capitalize on?
Rentokil has significant opportunities for growth, including deepening its penetration of the vast U.S. commercial and residential markets by leveraging its expanded operations after the Terminix deal. Cross-selling and upselling of sanitation, disinfection, and other value-added services to its large customer base can drive additional wallet share. Further acquisitions, especially in high-growth or under-served regions, could expand its global footprint. Digital innovation and enhanced use of data and technology can improve service efficiency, customer experience, and product differentiation. Macro trends toward stricter hygiene standards post-pandemic and greater awareness of public health issues offer tailwinds for expanding both classic pest control and related services.
What risks could impact the company?
Major risks include unsuccessful integration of Terminix, which could lead to missed synergy targets, cost overruns, customer attrition, and reputation damage. General economic slowdowns or recessions could hurt spending on non-essential services, partially impacting revenue streams. The competitive landscape, with aggressive moves from players like Rollins and Ecolab, could result in pricing pressure or market share erosion. Regulatory changes, particularly in chemical usage or environmental practices, pose compliance and cost risks. Finally, activist investor involvement, while potentially value-enhancing, could create volatility or strategic distractions for management.
What’s the latest news about the company?
Recent noteworthy news about Rentokil Initial includes a stock price surge following activist investor Trian Partners and Nelson Peltz taking a major stake and engaging constructively with Rentokil management to explore potential paths to enhance shareholder value. Multiple hedge funds and active managers such as Voss Capital and Vulcan Value Partners have cited bullish positions in the company based on its integration of Terminix, recurring revenue advantages, and long-term growth prospects. The company received an upgrade to a 'Buy' rating from Zacks due to positive earnings momentum. Despite these affirmations, some integration challenges have kept the stock from becoming a top holding among hedge funds. Nonetheless, market commentary remains largely positive on Rentokil’s fundamentals and strategic direction.
What market trends are affecting the company?
Broader market trends affecting Rentokil include the continued strength of large-cap equities, a focus on defensive sectors amidst economic uncertainty, and increased investor appetite for companies with high recurring revenues and stable cash flows. Other industry-wide shifts, such as heightened hygiene and health standards post-pandemic, are increasing demand for professional pest and sanitation services worldwide. The pest control industry continues to see consolidation as major players pursue scale and operational efficiency. Additionally, activist investor involvement is on the rise, with funds seeking to unlock value in established service businesses like Rentokil. Inflation, while easing, and global economic conditions remain macro factors to monitor for overall service sector performance.
Price change
$28.68
